Elkhorn Investments’s Celgene Corp CELG Stock Holding History

Elkhorn Investments’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,559	Closed	-$643K	–	200
2016 Q4	$643K	Buy	+5,559	New	+$619K	0.75%	92

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Elkhorn Investments's CELG Position: Q1 2017 in Review

Elkhorn Investments sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 5,559 shares — an estimated $643K sold.

Elkhorn Investments first reported a position in CELG in Q4 2016 and held it in 1 quarter. The position peaked at $643K in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Elkhorn Investments reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Elkhorn Investments sold 5,559 Celgene Corp shares in Q1 2017, an estimated $643K.
Elkhorn Investments first reported a position in Celgene Corp in Q4 2016 and held it in 1 quarter.
Elkhorn Investments's Celgene Corp position peaked at $643K in Q4 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Elkhorn Investments's 13F filing for Q1 2017, filed 2 May 2017.